SMN oligomerization defect correlates with spinal muscular atrophy severity

Area of Science:

• Genetics
• Molecular Biology
• Neuroscience

Background:

• Spinal muscular atrophy (SMA) is a severe genetic motor-neuron disorder caused by anterior-horn-cell death.
• It is the most common genetic cause of infant death, with a carrier frequency of 1 in 50.
• SMA is classified into types I-III based on clinical severity and age of onset.

Purpose of the Study:

• To investigate the role of the survival motor neuron (SMN) gene in SMA pathogenesis.
• To identify the biochemical defect underlying different clinical types of SMA.
• To explore the correlation between SMN protein oligomerization and disease severity.

Main Methods:

• Identification of a modular oligomerization domain within exon 6 of the SMN1 gene.
• Analysis of wild-type and mutant SMN proteins from SMA patients (types I-III).
• Comparison of SMN protein self-association in different SMA types and with a centromeric SMN product.

Main Results:

• A direct correlation was observed between SMN protein oligomerization and the clinical type of SMA.
• All previously identified missense mutations in SMA patients mapped to or near the identified oligomerization domain.
• The centromeric SMN product, lacking exon 7, showed reduced self-association.

Conclusions:

• Decreased SMN protein self-association is identified as a biochemical defect in spinal muscular atrophy.
• Disease severity in SMA is proportional to the concentration of oligomerization-competent SMN proteins.
• These findings offer insights into SMA pathogenesis and potential therapeutic targets.